{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:33:05Z","timestamp":1761561185832},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.ijcard.2007.05.060","type":"journal-article","created":{"date-parts":[[2007,8,30]],"date-time":"2007-08-30T11:15:15Z","timestamp":1188472515000},"page":"249-252","source":"Crossref","is-referenced-by-count":10,"title":["Mutation-specific effects of lidocaine in Brugada syndrome"],"prefix":"10.1016","volume":"121","author":[{"given":"Colleen E.","family":"Clancy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xander H.T.","family":"Wehrens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ijcard.2007.05.060_bib1","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/01.CIR.97.5.457","article-title":"Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease","volume":"97","author":"Brugada","year":"1998","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ijcard.2007.05.060_bib2","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1161\/01.CIR.96.8.2595","article-title":"Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men","volume":"96","author":"Nademanee","year":"1997","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ijcard.2007.05.060_bib3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1540-8167.1998.tb01844.x","article-title":"The Brugada syndrome","volume":"9","author":"Antzelevitch","year":"1998","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"9","key":"10.1016\/j.ijcard.2007.05.060_bib4","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1161\/01.CIR.102.9.945","article-title":"The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge","volume":"102","author":"Priori","year":"2000","journal-title":"Circulation"},{"issue":"6673","key":"10.1016\/j.ijcard.2007.05.060_bib5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/32675","article-title":"Genetic basis and molecular mechanism for idiopathic ventricular fibrillation","volume":"392","author":"Chen","year":"1998","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.ijcard.2007.05.060_bib6","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1172\/JCI16945","article-title":"Defective cardiac ion channels: from mutations to clinical syndromes","volume":"110","author":"Clancy","year":"2002","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.ijcard.2007.05.060_bib7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.hrthm.2005.01.005","article-title":"Brugada syndrome: report of the second consensus conference","volume":"2","author":"Antzelevitch","year":"2005","journal-title":"Heart Rhythm"},{"issue":"8","key":"10.1016\/j.ijcard.2007.05.060_bib8","doi-asserted-by":"crossref","first-page":"E37","DOI":"10.1161\/01.RES.87.8.e37","article-title":"Enhanced Na(+) channel intermediate inactivation in Brugada syndrome","volume":"87","author":"Wang","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.ijcard.2007.05.060_bib9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijcard.2007.02.007","article-title":"A paradoxal effect of lidocaine for the N406S mutation of SCN5A associated with Brugada syndrome","volume":"121","author":"Itoh","year":"2007","journal-title":"Int J Cardiol"},{"issue":"5","key":"10.1016\/j.ijcard.2007.05.060_bib10","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1540-8167.2005.40711.x","article-title":"A novel missense mutation in the SCN5A gene associated with Brugada syndrome bidirectionally affecting blocking actions of antiarrhythmic drugs","volume":"16","author":"Itoh","year":"2005","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"15","key":"10.1016\/j.ijcard.2007.05.060_bib11","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1161\/01.CIR.100.15.1660","article-title":"Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation","volume":"100","author":"Yan","year":"1999","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ijcard.2007.05.060_bib12","doi-asserted-by":"crossref","first-page":"H399","DOI":"10.1152\/ajpheart.01025.2005","article-title":"Sodium channel kinetic changes that produce Brugada syndrome or progressive cardiac conduction system disease","volume":"292","author":"Zhang","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"10.1016\/j.ijcard.2007.05.060_bib13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2165\/00129785-200303030-00003","article-title":"Mutations in cardiac sodium channels: clinical implications","volume":"3","author":"Liu","year":"2003","journal-title":"Am J Pharmacogenomics"},{"issue":"2","key":"10.1016\/j.ijcard.2007.05.060_bib14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1213\/00000539-199008000-00008","article-title":"Fundamental properties of local anesthetics. II. Measured octanol:buffer partition coefficients and pKa values of clinically used drugs","volume":"71","author":"Strichartz","year":"1990","journal-title":"Anesth Analg"},{"issue":"17","key":"10.1016\/j.ijcard.2007.05.060_bib15","doi-asserted-by":"crossref","first-page":"9270","DOI":"10.1073\/pnas.93.17.9270","article-title":"Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na+ channels","volume":"93","author":"Ragsdale","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.ijcard.2007.05.060_bib16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1085\/jgp.20028723","article-title":"Common molecular determinants of flecainide and lidocaine block of heart Na+ channels: evidence from experiments with neutral and quaternary flecainide analogues","volume":"121","author":"Liu","year":"2003","journal-title":"J Gen Physiol"},{"issue":"Pt 3","key":"10.1016\/j.ijcard.2007.05.060_bib17","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1469-7793.1998.693bd.x","article-title":"Mechanistic link between lidocaine block and inactivation probed by outer pore mutations in the rat micro1 skeletal muscle sodium channel","volume":"512","author":"Kambouris","year":"1998","journal-title":"J Physiol"},{"issue":"3","key":"10.1016\/j.ijcard.2007.05.060_bib18","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1152\/physrev.1981.61.3.644","article-title":"Sodium channels and gating currents","volume":"61","author":"Armstrong","year":"1981","journal-title":"Physiol Rev"},{"issue":"6","key":"10.1016\/j.ijcard.2007.05.060_bib19","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1124\/mol.105.014803","article-title":"Molecular modeling of local anesthetic drug binding by voltage-gated sodium channels","volume":"68","author":"Lipkind","year":"2005","journal-title":"Mol Pharmacol"},{"issue":"21","key":"10.1016\/j.ijcard.2007.05.060_bib20","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.2174\/1381612054546833","article-title":"Mechanism of local anesthetic drug action on voltage-gated sodium channels","volume":"11","author":"Fozzard","year":"2005","journal-title":"Curr Pharm Des"},{"issue":"9","key":"10.1016\/j.ijcard.2007.05.060_bib21","doi-asserted-by":"crossref","first-page":"E91","DOI":"10.1161\/01.RES.86.9.e91","article-title":"Two distinct congenital arrhythmias evoked by a multidysfunctional Na(+) channel","volume":"86","author":"Veldkamp","year":"2000","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/j.ijcard.2007.05.060_bib22","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1161\/hc3501.093797","article-title":"Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromes","volume":"104","author":"Viswanathan","year":"2001","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ijcard.2007.05.060_bib23","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1161\/01.RES.0000091829.63501.A8","article-title":"Antiarrhythmic drug target choices and screening","volume":"93","author":"Sanguinetti","year":"2003","journal-title":"Circ Res"},{"issue":"6542","key":"10.1016\/j.ijcard.2007.05.060_bib24","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/376683a0","article-title":"Molecular mechanism for an inherited cardiac arrhythmia","volume":"376","author":"Bennett","year":"1995","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.ijcard.2007.05.060_bib25","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1161\/hh0701.089668","article-title":"Novel arrhythmogenic mechanism revealed by a long-QT syndrome mutation in the cardiac Na+ channel","volume":"88","author":"Abriel","year":"2001","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.ijcard.2007.05.060_bib26","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1124\/mol.62.2.415","article-title":"Prenylamine block of Nav1.5 channel is mediated via a receptor distinct from that of local anesthetics","volume":"62","author":"Mujtaba","year":"2002","journal-title":"Mol Pharmacol"},{"issue":"5","key":"10.1016\/j.ijcard.2007.05.060_bib27","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1124\/mol.106.027177","article-title":"An inner pore residue (Asn406) in the Nav1.5 channel controls slow inactivation and enhances mibefradil block to T-type Ca2+ channel levels","volume":"70","author":"McNulty","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.ijcard.2007.05.060_bib28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/3-540-29715-4_4","article-title":"Cardiac Na+ channels as therapeutic targets for antiarrhythmic agents","volume":"171","author":"Glaaser","year":"2006","journal-title":"Handb Exp Pharmacol"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527307010777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527307010777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,26]],"date-time":"2020-04-26T06:21:06Z","timestamp":1587882066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527307010777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0167527307010777"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2007.05.060","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}